Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure
- PMID: 15300587
- DOI: 10.1053/j.gastro.2004.04.063
Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure
Abstract
Background & aims: Gut-derived peptides including ghrelin, cholecystokinin (CCK), peptide YY (PYY), glucagon-like peptide (GLP-1), and GLP-2 exert overlapping actions on energy homeostasis through defined G-protein-coupled receptors (GPCRs). The proglucagon-derived peptide (PGDP) oxyntomodulin (OXM) is cosecreted with GLP-1 and inhibits feeding in rodents and humans; however, a distinct receptor for OXM has not been identified.
Methods: We examined the mechanisms mediating oxyntomodulin action using stable cell lines expressing specific PGDP receptors in vitro and both wild-type and knockout mice in vivo.
Results: OXM activates signaling pathways in cells through glucagon or GLP-1 receptors (GLP-1R) but transiently inhibits food intake in vivo exclusively through the GLP-1R. Both OXM and the GLP-1R agonist exendin-4 (Ex-4) activated neuronal c-fos expression in the paraventricular nucleus of the hypothalamus, the area postrema, and the nucleus of the solitary tract following intraperitoneal (i.p.) injection. However, OXM transiently inhibited food intake in wild-type mice following intracerebroventricular (i.c.v.) but not i.p. administration, whereas Ex-4 produced a more potent and sustained inhibition of food intake following both i.c.v. and i.p. administration. The anorectic effects of OXM were preserved in Gcgr(-/-) mice but abolished in GLP-1R(-/-) mice. Although central Ex-4 and OXM inhibited feeding via a GLP-1R-dependent mechanism, Ex-4 but not OXM reduced VO2 and respiratory quotient in wild-type mice.
Conclusions: These findings demonstrate that structurally distinct PGDPs differentially regulate food intake and energy expenditure by interacting with a GLP-1R-dependent pathway. Hence ligand-specific activation of a common GLP-1R increases the complexity of gut-central nervous system pathways regulating energy homeostasis and metabolic expenditure.
Similar articles
-
Central pre-proglucagon derived peptides: opportunities for treatment of obesity.Curr Pharm Des. 2003;9(17):1373-82. doi: 10.2174/1381612033454775. Curr Pharm Des. 2003. PMID: 12769729 Review.
-
The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.Endocrinology. 2008 Nov;149(11):5670-8. doi: 10.1210/en.2008-0336. Epub 2008 Jul 31. Endocrinology. 2008. PMID: 18669601
-
A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.Diabetes. 2004 Sep;53(9):2492-500. doi: 10.2337/diabetes.53.9.2492. Diabetes. 2004. PMID: 15331566
-
Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor.Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R962-70. doi: 10.1152/ajpregu.00405.2006. Epub 2006 Oct 12. Am J Physiol Regul Integr Comp Physiol. 2007. PMID: 17038440
-
Glucagon and glucagon-like peptide receptors as drug targets.Curr Pharm Des. 2006;12(14):1731-50. doi: 10.2174/138161206776873671. Curr Pharm Des. 2006. PMID: 16712485 Review.
Cited by
-
Molecular mechanisms of appetite regulation.Diabetes Metab J. 2012 Dec;36(6):391-8. doi: 10.4093/dmj.2012.36.6.391. Epub 2012 Dec 12. Diabetes Metab J. 2012. PMID: 23275931 Free PMC article.
-
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.Diabetes. 2009 Oct;58(10):2258-66. doi: 10.2337/db09-0278. Epub 2009 Jul 14. Diabetes. 2009. PMID: 19602537 Free PMC article.
-
Physiological Appetite Regulation and Bariatric Surgery.J Clin Med. 2024 Feb 27;13(5):1347. doi: 10.3390/jcm13051347. J Clin Med. 2024. PMID: 38546831 Free PMC article. Review.
-
Gut hormone co-agonists for the treatment of obesity: from bench to bedside.Nat Metab. 2023 Jun;5(6):933-944. doi: 10.1038/s42255-023-00812-z. Epub 2023 Jun 12. Nat Metab. 2023. PMID: 37308724 Review.
-
β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues.J Am Chem Soc. 2016 Nov 16;138(45):14970-14979. doi: 10.1021/jacs.6b08323. Epub 2016 Nov 4. J Am Chem Soc. 2016. PMID: 27813409 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases